Risk factors

TAO Synergies (TAOX) risk factors

Item 1A of every TAO Synergies Inc. 10-K on file, and what changed from one year to the next.

Open TAOX in Gloomberb →
  • FY2025 10-K risk factors

    68 risks, 30 new, 5 dropped, 7 reworded since the prior year. Company pivoted into a crypto strategy aiming to acquire $100 million of TAO tokens, relying heavily on consultant James Altucher.

    Filed Mar 31, 2026
  • FY2024 10-K risk factors

    43 risks. TAO Synergies faces high reliance on its lead drug Bryostatin-1, which failed its primary Phase 2 endpoint.

    Filed Mar 27, 2025